Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Other 1

Conditions

Urinary Bladder Neoplasms 1Respiratory Sounds 1Postoperative Complications 1Liver Cirrhosis 1Leukemia 1Hypoxia 1Hemorrhage 1Edema 1Dyspnea, Paroxysmal 1Dyspnea 1Brain Neoplasms 1

Interventions

fluoroazomycin arabinoside 33-fluoro-2-(4-((2-nitro-1H-imidazol-1-yl)methyl)-1H-1,2,3-triazol-1-yl)propan-1-ol 3pimonidazole 2Propofol 2Blood Specimen Collection 2gadobutrol 1Sevoflurane 1Radiotherapy 1Pancreaticoduodenectomy 1Oxygen 1Ketamine 1Gemcitabine 1Furosemide 1Exercise 1Diagnostic Imaging 1Biopsy 14-methylbenzenesulfonic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Hypoxia × Furosemide × Clear all
NCT01508260 2013-04-05

Ultrafiltration (Aquapheresis) in Patients With Leukemia and Severe Fluid Overload

M.D. Anderson Cancer Center

Phase NA Withdrawn
OtherOther hematologic neoplasm

Hypoxia, Dyspnea, Dyspnea, Paroxysmal, Edema, Leukemia, Respiratory Sounds

Data powered by HemOnc (CC BY 4.0) Colophon âš¡